Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05800119 · ClinicalTrials.gov registry record · NA
An Intervention to Correct Dualistic Reasoning About the Effectiveness of Psychotherapy for Biologically Caused Mental Disorders
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,243
- Enrollment target
NCT05800119 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,243 participants.
The verdict
NCT05800119, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,243 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test in three samples, including sample 1: lay people without reported depression symptoms, sample 2: lay people with reported depression symptoms and sample 3: mental health clinicians. The main questions it aims to answer are: 1) do each of these populations show a bias against psychotherapy wherein they judge psychotherapy to be less effective, relative to baseline ratings, when a mental illness (i.e., depression) is attributed to biological factors, 2) whether an intervention emphasizing the neurobiological effects of psychotherapy can remove this bias against psychotherapy for biologically-caused mental disorders, and 3) whether this intervention is more effective compared to an active control intervention that emphasizes the effectiveness of psychotherapy, but not its neurobiological effects. Participants will * rate the effectiveness of psychotherapy for depression before and after learning about the biological causes of depression * be assigned to one of three conditions: 1) an intervention condition where participants will receive a brief reading passage (approximately 126 words in length) providing psychoeducation about how psychotherapy changes the brain of an individual with depression, or 2) an active control condition where participants will receive a reading passage (approximately 115 words) emphasizing the effectiveness of psychotherapy, or 3) a control condition where they will receive no additional materials * as a secondary outcome, participants will also rate the effectiveness of medication for depression, before and after learning about the biological causes of depression
Interventions
- BEHAVIORAL Brain-level condition
- OTHER Mind-level condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,243 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2022-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05800119
The ClinicalTrials.gov registry entry for NCT05800119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brain-level condition is the first listed.
NCT05800119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05800119 about?
NCT05800119 is a clinical study titled "An Intervention to Correct Dualistic Reasoning About the Effectiveness of Psychotherapy for Biologically Caused Mental Disorders". The goal of this clinical trial is to test in three samples, including sample 1: lay people without reported depression symptoms, sample 2: lay people with reported depression symptoms and sample 3: mental health clinicians. The main questions it aims to answer are: 1) do each of these populations s...
What is the current status of trial NCT05800119?
This trial is currently completed. It is a NA study. The enrollment target is 1,243 participants. The study started on 2020-09-18. Estimated completion is 2022-04-02.
What interventions are being tested in trial NCT05800119?
The interventions under investigation include: Brain-level condition (BEHAVIORAL), Mind-level condition (OTHER).
Who is sponsoring clinical trial NCT05800119?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.